Persistent URL of this record https://hdl.handle.net/1887/88284
In Collections
This item can be found in the following collections:
![HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE RANDOMIZED PHASE II TAVAREC TRIAL ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB IN 1p/19q INTACT FIRS RECURRENCE WHO GRADE II AND III GLIOMA (EORTC 26091)
- All authors
- Reijneveld, J.C.; Coens, C.; Taphoorn, M.J.B.; Smitt, P.S.; Clement, P.M.; Idbaih, A.; Vos, F. de; Klein, M.; Wick, W.G.; Mulholland, P.; Lewis, J.; Golfinopoulos, V.; Bottomley, A.; Bent, M. van den
- Date
- 2017-11-30
- Journal
- Neuro-Oncology
- Volume
- 19
- Pages
- 203 - 203